Study Reveals Extensive Benefits of Emergency Department Clinical Trials

A new study published in JAMA Network Open reveals that participation in emergency department-based clinical trials delivers substantial benefits that extend far beyond improved patient outcomes. The study, co-led by Gail D’Onofrio, MD, MS, Albert E. Kent Professor of Emergency Medicine at Yale School of Medicine, offers compelling evidence that clinical research can be a catalyst for positive change across multiple domains.

The cross-sectional survey, co-led by Joseph E. Carpenter, MD, from Emory University School of Medicine, examined investigators who participated in the ED-INNOVATION (Emergency Department–Initiated Buprenorphine and Validation Network) trial, which spanned 33 emergency departments (EDs) across 23 states. The trial compared initiation of extended-release injectable buprenorphine with traditional sublingual buprenorphine and treatment engagement after the emergency department visit, addressing evidence-based care for opioid use disorder (OUD) in acute care settings.

According to D’Onofrio, ED INNOVATION lead investigator, “Participation in clinical trials can improve patient care while also strengthening the emergency medicine research pipeline—an area in need of sustained support and development. By engaging emergency department physicians in research activities, the trial built capacity, expanded investigator expertise, and positioned sites for future federally funded studies.”

The study documented remarkable institutional impacts from trial participation. One survey respondent noted that involvement in the clinical trial "completely changed the culture of our ED," highlighting how research engagement can fundamentally reshape clinical practice environments. Participating institutions reported widespread practice changes that extended well beyond the trial's specific focus, demonstrating how clinical trials can drive sustainable quality improvement in emergency care.

Individual clinicians experienced significant professional benefits from their involvement in the multi-site emergency medicine clinical trial. Site directors became more research-active, submitting additional funding proposals following their participation. Some clinicians obtained advanced certification in addiction medicine as a direct result of their trial participation, demonstrating that National Institutes of Health-supported clinical research can serve as a pathway to specialized expertise, leadership development, and career advancement.

The ED-INNOVATION trial successfully engaged a diverse array of community partners, including organizations and settings that could reach at-risk patients. This community-oriented approach demonstrates how clinical research can extend its impact beyond hospital walls to support broader public health initiatives and address social determinants of health.

The findings come at a crucial time when clinical research infrastructure faces mounting pressures. The study underscores the multifaceted value of investing in emergency medicine clinical trials, suggesting that research funding generates returns not only through improved patient care but also through institutional development, workforce enhancement, and community strengthening.